| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |